UPA ELISA Kits Market: Advancing Prognostic Testing in Oncology

a adăugat un sunet Health

2026-08-04 07:55:24 -

Market Overview The UPA ELISA Kits Market is growing as urokinase plasminogen activator testing gains recognition as a prognostic biomarker in breast cancer management. The market is projected to grow through 2030, driven by rising breast cancer diagnosis rates, growing adoption of biomarker-guided treatment decisions, expanding oncology research applications, and increasing laboratory...

0 Commentarii 0 Distribuiri 4 Views 0 previzualizare